Pancreatic Cancer Research

ResearcherMarche Polytechnic UniversityActive in the last 2 years

Luca Faloppi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3689-3085; OpenAlex author ID A5006012062. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
30
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 7

  1. Exploring external validity of chemotherapy for pancreatic ductal adenocarcinoma in real life. Co-author DOI 10.1016/j.dld.2024.06.025↗
  2. A pilot study of chlorambucil in pre-treated metastatic pancreatic adenocarcinoma patients bearing germline BRCA or other DNA damage repair system variants. Co-author DOI 10.1016/j.pan.2024.09.006↗
  3. Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus. Co-author DOI 10.1177/0300891620976945↗
  4. [Treatment of pancreatic cancer. Actuality and perspective]. Co-author DOI 10.1701/1868.20404↗
  5. The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib. Co-author DOI 10.18632/oncotarget.5197↗
  6. Sorafenib does not improve efficacy of chemotherapy in advanced pancreatic cancer: A GISCAD randomized phase II study. Co-author DOI 10.1016/j.dld.2013.09.020↗
  7. Cetuximab: still an option in the treatment of pancreatic cancer? Co-author DOI 10.1517/14712598.2013.786697↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Stefano Cascinu · 6 shared papers, 2013–2025 · strength 0.47
  2. Giulia Orsi · 3 shared papers, 2021–2025 · strength 0.47
  3. Umberto Peretti · 2 shared papers, 2024–2025 · strength 0.37
  4. Marina Macchini · 2 shared papers, 2024–2025 · strength 0.37
  5. Michele Reni · 2 shared papers, 2024–2025 · strength 0.37
  6. Mario Scartozzi · 3 shared papers, 2015–2024 · strength 0.31
  7. Kalliopi Andrikou · 4 shared papers, 2013–2021 · strength 0.24
  8. Letizia Procaccio · 1 shared paper, 2025 · strength 0.20
  9. Vincenzo Formica · 1 shared paper, 2025 · strength 0.20
  10. Vincenzo Ricci · 1 shared paper, 2025 · strength 0.20
  11. Guido Giordano · 1 shared paper, 2025 · strength 0.20
  12. Ilario Giovanni Rapposelli · 1 shared paper, 2025 · strength 0.20
  13. Andrea Spallanzani · 1 shared paper, 2024 · strength 0.18
  14. Catia Carconi · 1 shared paper, 2024 · strength 0.18
  15. Sara Lonardi · 1 shared paper, 2024 · strength 0.18
  16. Ingrid Garajová · 1 shared paper, 2024 · strength 0.18
  17. Rosella Spadi · 1 shared paper, 2024 · strength 0.18
  18. Irene Pecora · 1 shared paper, 2024 · strength 0.18
  19. Andrea Pretta · 1 shared paper, 2021 · strength 0.09
  20. Eleonora Lai · 1 shared paper, 2021 · strength 0.09
  21. Giulia Rovesti · 1 shared paper, 2021 · strength 0.09
  22. Alessandro Bittoni · 2 shared papers, 2015 · strength 0.09
  23. Roberto Labianca · 2 shared papers, 2014–2015 · strength 0.07
  24. Stefania Mosconi · 2 shared papers, 2014–2015 · strength 0.07
  25. Sandro Barni · 2 shared papers, 2014–2015 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.